Cure Pharmaceutical on Tuesday announced it will acquire privately held Sera Labs in Sherman Oaks for $20 million.
Amgen Inc. beat analyst expectations during the second quarter, despite the effects of the coronavirus on the health care industry.
Arcutis Biotherapeutics on Monday announced the appointment of Dr. Patrick Burnett as its chief medical officer effective Aug. 1.
Thousand Oaks biotech Amgen Inc. on Tuesday announced the renewal of a $3 million grant to Khan Academy.
Medtronic executive Alejandro Galindo will join MannKind Corp. as its chief commercial officer effective Aug. 4.
A Los Angeles skilled nursing home operator will pay $16.7 million to settle allegations with the Department of Justice that it submitted false claims to Medicare for rehabilitation therapy services that were unreasonable or unnecessary.
Amgen on Sunday announced an additional investment of $421 million in Chinese biotech Beigene, adjusting its stock ownership to 20.3 percent.
Medtronic has signed a patent cross-license agreement with San Diego-based Tandem Diabetes Care to avoid potential legal disagreements.
Providence Cedars-Sinai Tarzana Medical Center Chief Executive Dale Surowitz will leave his post to lead the Los Angeles Jewish Home during a time of rapid expansion.
Shareholders of ImmunoCellular Therapeutics have voted to implement a reverse stock split at a ratio not less than 1-for-3 and not greater than 1-for-10.
A new medical clinic opened on the Henry Mayo Newhall Hospital campus in Valencia earlier this week.
Shares of MannKind Corp. (MNKD) jumped nearly 17 percent on Monday, following positive data presented at an American Diabetes Association event about the company’s flagship product, Afrezza.
Adventist Health has partnered with North Carolina health care improvement company Premier Inc. to acquire a minority stake in Prestige Ameritech — one of the largest domestic manufacturers of personal protective equipment.
Health care system Kaiser Permanente has released a 98-page “playbook” for businesses returning to the office, with insight from the Centers for Disease Control and Prevention and Occupational Safety and Health Administration, as well as state and county health departments.
Lancaster biotech Simulations Plus has won a $400,000 grant as part of a cooperative agreement with the U.S. Food and Drug Administration, the company said in a statement Thursday.